FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/076068 [Registered on: 29/10/2024] Trial Registered Prospectively
Last Modified On: 08/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   a study of Agnimantha both species to find efficacy in increasing blood hemoglobin level. 
Scientific Title of Study   A COMPARATIVE PHARMACO-CLINICAL STUDY OF AGNIMANTHA (PREMNA INTEGRIFOLIA LINN & CLERODENDRUM PHLOMIDIS LINN.) IN PANDU ROGA W.S.R. TO IRON DEFICIENCY ANEMIA. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrTej singh Jatav 
Designation  MD Scholar 
Affiliation  Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute  
Address  Room no 226 Department of Dravyaguna Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute Science Hills behind MANIT Bhopal Madya Pradesh

Bhopal
MADHYA PRADESH
462003
India 
Phone  9893186235  
Fax    
Email  dr.tsjohari@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vinod Sharma 
Designation  Reader Dravyaguna 
Affiliation  Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute  
Address  Room no 226 Department of Dravyaguna Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute Science Hills behind MANIT Bhopal Madya Pradesh

Bhopal
MADHYA PRADESH
462003
India 
Phone  9926379195  
Fax    
Email  sharmavinod389@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrTej singh Jatav 
Designation  MD Scholar 
Affiliation  Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute  
Address  Room no 226 Department of Dravyaguna Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute Science Hills behind MANIT Bhopal Madya Pradesh

Bhopal
MADHYA PRADESH
462003
India 
Phone  9893186235  
Fax    
Email  dr.tsjohari@gmail.com  
 
Source of Monetary or Material Support  
Pt. Khusi Lal Sharma Government Ayurveda College and Institute Science Hills behind MANIT Bhopal Madhya Pradesh Pincode 462003  
 
Primary Sponsor  
Name  Pt. Khusi Lal Sharma Government Ayurveda College and Institute  
Address  Pt. Khusi Lal Sharma Government Ayurveda College and Institute Science Hills behond MANIT Bhopal Madhya Pradesh 
Type of Sponsor  Other [State Government Ayurvedic College and institute] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrTej Singh Jatav  Pt Khusi Lal Sharma Government (Autonomous)Ayurveda college and institute   OPD no 1 Department of Kaya Chikitsa
Bhopal
MADHYA PRADESH 
09893186235

dr.tsjohari@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee Pt Khusi Lal Sharma Government Ayurved College and Institute Science Hills Bhopal  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Laghu Agnimantha Clerodendrum Phlomidis Linn, Reference: Kaidev nighantu Aushadhi varga 27, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Brihat Agnimantha Premna integrifolia linn, Reference: Bhav Prakah Guduchyadi varga 24, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Individuals aged between 15 to 55 years without any discrimination of gender, caste, religion, etc.
2. Patients fulfilling the diagnostic criteria.
3. Individuals having clinical Sign and symptoms of Pandu according to Ayurvedic classics.
4. Individuals who will give written consent for the study.
5. Hb% between 8 gm to 11gm.
 
 
ExclusionCriteria 
Details  1. Individuals having any known systemic disorders like Cardiac disorders, Renal and Hepatic impairment, Diabetes Mellitus, Thyroid disorders, Gynecological diseases, and any type of Cancers.
2. Pregnancy and Lactating mothers.
3. Others type of known anemia like hemolytic, megaloblastic, pernicious, sickle cell and all types of secondary congenital hereditary and genetically acquired anemia will be excluded.
4. Hb level less than 8 gm/dl.
5. Individuals below 15 years and above 55 years.
6. Any continuing blood loss e.g., Hematemesis, Melena, bleeding piles, etc.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Relief in Pandu Roga Subjective parameters
1.Panduta (Pallor of the body)
2.Anna-Aruchi (Loss of appetite)
3.Pindikoudvesthan (Cramp in calf region).
4.Akchikutshotha (Periorbitledema)
5. Dourbalya (Weakness)
6. Ayasena Shwasa (exertional dyspnoea)
7.Hriday Spandana (Palpitation)
 
subjective parameters will be compared after 30-days intervals. 
 
Secondary Outcome  
Outcome  TimePoints 
Change in Mean Haemoglobin level and Relief in objective parameters Like CBC, ESR  objective parameters like CBC and ESR will be compared after 30-day intervals. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Applicable 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

NEED OF STUDY: -  Anemia is a serious worldwide public health problem that particularly affects young children, mensurating women, adolescent girls, pregnant women, and post-partum women. Iron deficiency anemia can cause reduced work capacity in adults, impacting motor and mental development in children and adolescents. There is some evidence that iron deficiency anemia affects cognition in adolescent girls and causes fatigue in adult women. Iron deficiency anemia may affect visual and auditory functioning and is weakly associated with poor cognitive development in children.

 WHO estimates that 40% of children 6 months years of age, 37%of pregnant women, and 30%of women 15-49 years of age group worldwide are anemic. 

The aim of this study is To evaluate the comparative efficacy of drug Agnimantha’s varieties (Premna integrifolia & Clerodendrum phlomidis) in the management of Pandu roga.

open-labeled clinical study will be carried out by selected patients from OPD of the department of “Kaya Chikitsha at Pt. Khushi Lal Sharma Govt. (Auto.) Ayurveda College and

 Institute Bhopal. this study will be done on a total of 60 diagnosed patients of Pandu roga (Anemia especially Iron deficiency anemia) in two drug groups 

(A) Brihat Agnimantha (Premna integrifolia Linn.) and

(B) Laghu Agnimantha (Clerodendrum phlomidis Linn.f.) ghan vati. 

selected patients will be investigated by objective parameters  -  Complete Blood Count (CBC), ESR, And subjective parameters-

 1.   Panduta (Pallor of the body)

2.   Anna-Aruchi (Loss of appetite)

3.   Pindikoudvesthan (Cramp in calf region).

4.   Akchikutshotha (Periorbitledema)

5.   Dourbalya (Weakness)

6.   Ayasena Shwasa (exertional dyspnoea)

7.     Hriday Spandana (Palpitation)

The outcome of the study will be measured with the help of specially designed proforma and modern parameters.

 
Close